<SEC-DOCUMENT>0001571049-17-007378.txt : 20170810
<SEC-HEADER>0001571049-17-007378.hdr.sgml : 20170810
<ACCEPTANCE-DATETIME>20170810161044
ACCESSION NUMBER:		0001571049-17-007378
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170810
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170810
DATE AS OF CHANGE:		20170810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		171021573

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1700488_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
August 10, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Delaware</b></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction<br>
        of incorporation)</P></td>
    <td style="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>001-36745</b></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</P></td>
    <td style="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>59-2262718</b></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices;
zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging growth company
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.02&nbsp;&nbsp;Results of Operations and Financial
Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 10, 2017, Applied DNA Sciences, Inc. (&ldquo;Applied
DNA Sciences&rdquo; or the &ldquo;Company&rdquo;) issued a press release announcing its results of operations for the fiscal quarter
ended June 30, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information furnished pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly
set forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
Release of Applied DNA Sciences, Inc. dated August 10, 2017 regarding results of operations for the fiscal quarter ended June
30, 2017.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August 10, 2017</font></td>
    <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED DNA SCIENCES, INC.</font></td></tr>
<tr style="vertical-align: top">
    <td style="width: 51%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 42%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD NOWRAP STYLE="width: 11%; border-bottom: black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></font></td>
    <TD NOWRAP STYLE="width: 2%">&nbsp;</td>
    <TD NOWRAP STYLE="width: 87%; border-bottom: black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</font></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated August 10, 2017 regarding results of operations for the fiscal quarter&nbsp;&nbsp;ended June 30, 2017.</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>t1700488_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><IMG SRC="t1700488_logo.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Reports Fiscal Third Quarter
2017 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><I>Company
to Hold Conference Call and Webcast Today at 4:30 PM Eastern Time</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>STONY BROOK, N.Y., August 10, 2017 - </B>Applied DNA Sciences,
Inc. (NASDAQ: APDN) (&ldquo;Applied DNA&rdquo;, or &quot;the Company&quot;), announced financial results for the fiscal 2017 third
quarter ended June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&quot;We continued to make excellent progress in driving market
adoption of our DNA technology platform in the fiscal third quarter while generating strong sales growth from our most established
revenue-generating vertical from an initial cotton order for the upcoming ginning season,&rdquo; said Dr. James A. Hayward, president
and CEO of Applied DNA Sciences. &ldquo;In textiles, we see evidence that our technology platform is gaining momentum as brands
and retailers find it increasingly advantageous to provide assurances that the products on their shelves meet their product quality
claims. Our recently announced, more favorable licensing agreement with key cotton partner Himatsingka America, Inc. (&ldquo;Himatsingka&rdquo;)
illustrates the increasingly strategic role our molecular tag technology is playing in supporting manufacturers&rsquo; business
goals. In addition, product and customer reviews of Bed, Bath and Beyond&reg;&rsquo;s Wamsutta&reg; PimaCott&reg; home fashions
&ndash; manufactured by Himatsingka and incorporating our SigNature&reg; T technology &ndash; demonstrate that authenticity is
good for business. Beyond textiles, we also secured new revenue-generating awards in government/military and diagnostics verticals
that broaden our opportunities for revenue growth.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Third Quarter Financial Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues increased 175% for the third quarter of fiscal 2017 to $1.8
million, compared with $653 thousand reported in the third quarter of fiscal 2016, and increased 99% compared with revenues of
$905 thousand reported in the second fiscal quarter ended March 31, 2017. The increase in revenue is primarily attributable to
an increase in textile revenues.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses were $4.2 million, compared with $3.9 million
in the prior year&rsquo;s quarter, an increase of approximately 7%. The increase in total operating expenses is primarily attributable
to an increase associated with the write-off of an account receivable balance. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the quarter ended June 30, 2017 was $2.6 million, or
$0.10 per share, compared with a net loss of $3.4 million, or $0.14 per share for the quarter ended June 30, 2016 and a net loss
of $3.4 million, or $0.13 per share for the quarter ended March 31, 2017.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding non-cash expenses, Adjusted EBITDA for the quarter ended
June 30, 2017 was negative $1.5 million, compared to negative Adjusted EBITDA of $2.5 million for the same quarter last fiscal
year and negative Adjusted EBITDA of $2.7 million in the prior fiscal quarter. See below for information regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating activities in the third quarter
                                                                                                               of fiscal 2017 was $1.9 million. This compares with $2.2 million in the corresponding prior-year period. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continued Dr. Hayward, &ldquo;Business development activity
during the quarter was strong with pre-commercial opportunities growing to 14 active engagements at present from nine last quarter,&rdquo;
continued Dr. Hayward. &ldquo;Recently concluded pilot projects, such as in <I>Aloe vera</I>, touch upon multiple markets, from
food and supplements to pharmaceuticals and personal care. As announced earlier this week, large-scale fertilizer tagging, offers
the opportunity for large-scale deployments that address entire commercial ecosystems, as we do in cotton. While the timing of
conversion from pilot to commercial contract is uncertain, we remain focused on expanding the basket of opportunities and on shortening
sales cycles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;As we look ahead, we see several areas of
revenue growth. We believe that the start of the cotton ginning season and the growing &ldquo;pull&rdquo; we have experienced
from brands and from new categories in our existing retail channels will help catalyze sales and improve working-capital to
cash conversion. Business activity in non-cotton textile markets is also increasing as manufacturers of products
utilizing synthetic fibers move to our technology platform to their sales advantage. Lastly, through our success in cotton we
have been able to secure annual minimum revenue commitments from customers such as Loftex Home, LLC and GHCL Limited as
licensees of CertainT&trade;, our program that integrates our commercial platforms into a licensable strategy to generate
royalty fees, in addition to revenues from the sale of DNA taggant and testing services. CertainT is today a cornerstone of
our go-to-market strategy and a key component to building a diverse, recurring revenue base. With CertainT we can
participate not only at the front end of the supply chain with the application of our molecular tags, but at the back-end of the
value chain where the cumulative value-add is the highest and we can share in the economics with brands and retailers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concluded Dr. Hayward, &ldquo;We have been moving aggressively
to build the market for our technology platform and continue to expand our pipeline of opportunities. To help ensure that we have
the financial flexibility to capture the opportunities before us today, we have entered into binding private placement subscription
agreements with a key customer, as well as all executive officers and members of the board of directors. As we continue to build
our business, we believe our successes today will be the foundation for our sustained growth tomorrow.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Nine-Month Financial Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues for the first nine months of fiscal 2017 totaled $3.6 million,
an increase of 41% from the same period in the prior year.&nbsp;This increase was the result of an increase in product revenues
of $1.7 million, or 147%, primarily as a result of increased textile market sales. This increase was offset by a decrease in service
revenues from two government contract awards, both of which expired during the fourth quarter of the prior fiscal year. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses for the nine months ended June 30, 2017 increased
by $1.2 million or 10% for the same period last fiscal year. The increase is primarily attributable to an increase in stock-based
compensation and bad debt expense, offset by a decrease in R&amp;D due to the expiration of the two government contract awards.
</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the nine months ended June 30, 2017 was $10.0 million
or $0.38 per share, compared with a net loss of $9.8 million or $0.41 per share for the nine months ended June 30, 2016.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding non-cash expenses and interest, Adjusted EBITDA improved
for the nine months ended June 30, 2017 at a negative $6.6 million compared with an Adjusted EBITDA of negative $7.6 million for
the same period last fiscal year. See below for information regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Recent Business and Operational
Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On&nbsp;August 10, 2017, Applied DNA announced the start of production-scale
tagging of bearings with a global manufacturer. The work will be performed under the newly awarded Rapid Innovation Fund (RIF)
contract issued by the Office of the Secretary of Defense (OSD) on behalf of the Defense Logistics Agency (DLA). &nbsp;This production-scale
project is a follow-up to a successful pilot conducted under Applied DNA&rsquo;s prior OSD RIF contract, completed in August of
2016, and reflects the Company&rsquo;s ongoing efforts to commercialize processes and methodologies developed for Department of
Defense (DOD) applications and apply them to commercial OEMs.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On August 8, 2017, the Company announced that it had completed a pilot
project for the large-scale molecular tagging of a fertilizer that was successfully tracked through the West African supply chain
of the Rosier Group, SA, Belgium. The Company expects to begin shipments of fertilizer with molecular tags in early 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On July 18, 2017, Applied DNA announced that it had signed a new multi-year,
exclusive CertainT platform license agreement with&nbsp;Loftex Home, LLC, a well-respected manufacturer of high-quality towels
and home textiles, in connection with source verified recycled polyethylene terephthalate (PET). An expansion of the Company&rsquo;s
existing agreement with Loftex signed in March of this year, the new multi-year agreement is now exclusive for bath and beach towels
in the United States, non-exclusive for plush throws and bath rugs &nbsp;and provides for long term minimum annual revenues as
well as trademark licensing royalties to Applied DNA.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On July 11, 2017 as evidence of the Company&rsquo;s continuing penetration
of the non-cotton textile market, Applied DNA announced that it had signed a multi-year CertainT Platform license agreement with&nbsp;GHCL&nbsp;Limited,
a global manufacturer of home textiles. The agreement provides&nbsp;for CertainT&nbsp;platform&nbsp;services in connection with
source-verifiedPET and recycled PET (post consumer) in blended bed sheets, pillowcases, and shams sold in-store or online in the
United States. GHCL has also licensed Applied DNA&rsquo;s CertainT trademark for use on its products, as well as for promotional,
marketing and sales materials. The agreement provides for minimum annual revenues as well as trademark licensing royalties to Applied
DNA. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On July 5, 2017, Applied DNA announced the addition of two sponsors
to the Company&rsquo;s leather traceability project with&nbsp;BLC Leather Technology Centre&nbsp;(BLC): Scottish Leather Group
Ltd and Tong Hong Tannery. With these new additions, the research project now totals seven sponsors, including C&amp;J Clark International
and PUMA SE, among other global brands. The Research Project, initiated following the signing of a Research Agreement between the
two companies, seeks to develop and validate a robust SigNature&reg;&nbsp;T-based system to provide comprehensive and verifiable
leather traceability, from farm to finished products. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On June 28, 2017, the Company announced that it entered into subscription
agreements for a private placement of its Common Stock with a group of investors, including a key customer and all of the Company&rsquo;s
Executive Officers and members of the Board of Directors.&nbsp; No discounts or warrants were given to the investors. As a result
of the private placement, the Company agreed to issue 1,025,574 shares of common stock at a price of $1.76 per share for total
expected gross proceeds of $1,805,000.<FONT STYLE="font-size: 10pt; color: #0A0A0A; background-color: white">&nbsp;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On June 27, 2017, Applied DNA announced the signing of a new, exclusive
licensing agreement with Himatsingka America, Inc. with improved financial terms: 60-day payment terms, and discontinuation of
revenue-sharing to its partners, yielding enhanced margins to Applied DNA. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On June 27, 2017, the Company announced it had completed initial work
under a funded contract with&nbsp;Lily of the Desert, a leading US-based producer of&nbsp;<I>Aloe vera</I>&nbsp;products, whose
offerings include nutritional drinks, topical cr&egrave;mes and gels. The pilot studies defined by the agreement are designed to
demonstrate the feasibility of molecular tagging to create the industry&rsquo;s first traceable and authenticated&nbsp;<I>Aloe
vera</I>&nbsp;juices, from raw material to the manufacture of nutritional drinks and topical consumer products.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On June 23, 2017, Applied DNA announced that it received an initial
order to tag&nbsp;27.5 million pounds of cotton to kick off the 2017/2018 ginning season, composed of three US cotton varietals.
The three varietals are Pima, Delta and Acala, which fall under the&nbsp;Pimacott&reg;, HomeGrown&trade; LoneStar&trade; and HomeGrown
Acala&trade; programs. We believe the order demonstrates Applied DNA&rsquo;s success in further entrenching SigNature T DNA in
an established revenue-generating vertical and in extending the adoption of its proven technology platform.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On June 6, 2017, the Company announced that it has been awarded a
two-year, approximately $1.5 million competitive-bid development contract funded by the Office of the Secretary of Defense on behalf
of the Defense Logistics Agency (DLA). The award expands current platforms to improve DoD counterfeit risk mitigation, and was
granted via a Rapid Innovation Fund (RIF) that provides DLA with innovative technologies that can be rapidly inserted into acquisition
programs to meet specific defense needs. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On May 15, 2017, Applied DNA announced that it appointed Elizabeth
M. Schmalz Ferguson to its Board of Directors. Ms. Ferguson was selected to serve based on her sterling track record of accomplishments
as a strategist and product leader within the personal care industry. This appointment increased the total number of Board members
to eight.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On May 1, 2017, the Company announced the debut of its textile molecular
tag technology,&nbsp;SigNature&reg;&nbsp;T, in Bed Bath &amp; Beyond&reg;&rsquo;s Wamsutta&reg;&nbsp;line, featuring&nbsp;PimaCott&reg;,&nbsp;at
locations nationwide and online. SigNature T verifies that the Wamsutta home fashions products sold to consumers are pure Pima
cotton, grown in the San Joaquin Valley, California. Products include comforters,&nbsp;pillow cases and&nbsp;shams. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal 2017 Third Quarter Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company will hold a conference call and webcast to discuss
its fiscal 2017 third-quarter results on Thursday August 10, 2017 at 4:30 PM EST. To participate on the conference call, please
follow the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of
the call, due to the large number of expected participants, not all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">To Participate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dial-in and ask to be joined to the
Applied DNA Sciences earnings call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 1-844-887-9402</FONT></TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll: 1-412-317-6798</FONT></TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Live webcast:&nbsp;https://services.choruscall.com/links/apdn170810.html</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Replay (available 1 hour following
the conclusion of the live call):</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 1-877-344-7529</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll: 1-412-317-0088</FONT></TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Passcode: 10110378</FONT></TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">International replay Toll:&nbsp;https://services.choruscall.com/ccforms/replay.html</FONT></TD></TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Archived webcast:&nbsp;https://services.choruscall.com/links/apdn170810.html</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information about Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &ldquo;GAAP&rdquo; refers to accounting principles
generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and
presented in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined
in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a
numerical measure of a company&rsquo;s historical or future performance, financial position, or cash flows that either excludes
or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented
in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation
or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP
financial measure for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons
of the performance and results of operations of our core business. Our management believes that these non-GAAP financial measures
provide meaningful supplemental information regarding the performance of our business by excluding non-cash expenses that may not
be indicative of our recurring operating results. We believe this non-GAAP financial measure is useful to investors as it allows
for greater transparency with respect to key metrics used by management in its financial and operational decision making.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;EBITDA&rdquo;- is defined as earnings (loss) before interest
expense, income tax expense and depreciation and amortization expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Adjusted EBITDA&rdquo;- is defined as EBITDA adjusted
to exclude (i) stock-based compensation and (ii) other non-cash expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><IMG SRC="t1700488_image.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font: 9pt Sans-Serif; color: Red"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font: 9pt Sans-Serif; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #222222; background-color: white">Applied DNA
Sciences&nbsp;makes life real and safe by providing innovative, molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting,
fraud and diversion. The&nbsp;proprietary DNA-based &ldquo;CertainT<SUP>TM</SUP>&rdquo;&nbsp;Platform can be used to identify,
tag, track, and trace products, to help assure authenticity, origin, traceability and quality of products. SigNature<SUP>&reg;</SUP>&nbsp;DNA
describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions
such as SigNature<SUP>&reg;</SUP>&nbsp;T and fiberTyping<SUP>&reg;</SUP>, targeted toward textiles and apparel, BackTrac&trade;
and DNAnet<SUP>&reg;</SUP>, for anti-theft and loss prevention, and digitalDNA<SUP>&reg;</SUP>, providing powerful track- and-trace.
All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the
large-scale production of specific DNA sequences using the polymerase chain reaction.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Go to <B>adnas.com </B>for more information, events and to learn
more about how Applied DNA Sciences makes life real and safe.&nbsp;Applied DNA&rsquo;s Common stock is quoted on NASDAQ under the
symbol APDN, and its warrants are quoted under the symbol APDNW.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The statements made by APDN in this press release may be &ldquo;forward-looking&rdquo;
in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN&rsquo;s
future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties,
many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time
to time in APDN&rsquo;s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our quarterly
reports on Form 10-Q filed on February 9, 2017, May 11, 2017, and August 10, 2017, which are or will be&nbsp;available at www.sec.gov.
APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances
after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><B>Investor contact: </B>Sanjay
M. Hurry, 212-838-3777, LHA, <B>shurry@lhai.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media contact: </B>Susan Forman, Dian Griesel Int&rsquo;l.,
212-825-3210,<B>sforman@dgicomm.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><B>web:</B> www.adnas.com<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in"><B>twitter: </B>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Financial Tables Follow</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">June 30, <BR> 2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">September 30, <BR> 2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: center; text-indent: -8.65pt; padding-left: 8.65pt">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 64%; text-align: left; padding-left: 8.65pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">2,402,809</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">4,479,274</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net of allowance of $37,773 and $32,965 at June 30, 2017 and September 30, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,746,010</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,374,895</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Stock subscriptions receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">505,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 8.65pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">376,520</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297,759</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.65pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">113,234</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">200,006</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,143,573</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,351,934</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Property, plant and equipment, net of accumulated depreciation of $1,565,153 at June 30, 2017 and $1,263,200 at September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">589,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792,499</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Other assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Long term accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,535,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 8.65pt">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,626</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,986</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net of accumulated amortization of $607,047 and $423,649 at June 30, 2017 and September 30, 2016, respectively</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,342,502</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,525,900</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 8.65pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,422,743</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,565,831</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,730,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,247,341</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.65pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">674,429</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,837,588</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,404,989</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,084,929</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Long term accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.65pt">Long term deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">900,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 8.65pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,404,989</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,200,429</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 8.65pt">Stockholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2017 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 10pt">Series A Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2017 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Series B Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2017 and September 30, 2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="padding-left: 10pt">Common stock, par value $0.001 per share; 500,000,000 shares authorized at June 30, 2017 and September 30, 2016; 27,377,057 and 24,078,756 shares issued and outstanding as of June 30, 2017 and September 30, 2016, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,079</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242,808,854</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,158,711</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-left: 10pt">Stock subscription receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,000,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(233,818,477</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(223,817,388</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,017,754</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,365,402</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 8.65pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 8.65pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,422,743</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,565,831</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center">Three Months Ended June 30,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center">Nine Months Ended June 30,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; text-align: left">Product revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,493,449</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">295,867</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2,887,054</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,167,452</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Service revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">303,933</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">357,029</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">718,709</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,382,880</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,797,382</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">652,896</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,605,763</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,550,332</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">232,348</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">180,559</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">804,552</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">735,692</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,402,817</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,576,891</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,534,105</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,185,149</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">603,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,149,146</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,757,616</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,861,599</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">161,441</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">168,641</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">486,786</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">557,968</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,167,353</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,894,678</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,778,507</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,604,716</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">LOSS FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,602,319</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,422,341</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,977,296</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,790,076</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">228</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,660</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,763</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,567</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other (expense) income , net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,758</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52,670</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(26,556</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,606</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Net loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,610,849</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,367,011</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,001,089</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,760,903</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,610,849</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,367,011</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(10,001,089</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(9,760,903</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.38</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Weighted average shares outstanding-</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;&nbsp;&nbsp;&nbsp;Basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">26,374,023</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,075,225</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">26,049,866</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">23,563,164</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.<BR>
CALCULATION AND RECONCILIATION OF ADJUSTED EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center">Three Months Ended June 30,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="text-align: center">Nine Months Ended June 30,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 40%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(2,610,849</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(3,367,011</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(10,001,089</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(9,760,903</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest (income) expense, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(228</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,660</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,763</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,567</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">168,641</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">486,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">557,968</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">566,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">567,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,562,300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,522,304</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">346,921</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">83,934</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">368,168</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">106,247</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,074,511</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">817,438</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,414,491</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,176,952</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,536,338</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,549,573</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(6,586,598</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(7,583,951</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>t1700488_image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 t1700488_image.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ M "T P$1  (1 0,1 ?_$ ,X    %!0$!
M       &!P@) 0($!0H#"P$!   ' 0$               (#! 4&!P@!"1
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M:BWKN1FKRD2)UC] 31/-I(1ZQR_["QP'[=:6W/Q+R7MM'=?MZRV%2]*>X?\
M4)/W2C;EEY'VI>FM7S2&ERR*@/QA297B?2[E8Y"P162;23&-XOT/E>W8TASP
M+^F7"Z1BL<^83!)TL>XG&$6ZDX9LX=M6SD$%U4@'Y=QWL/Z[<+<$MUC.FH:;
M+8)!FD',%.>&,O.+B++0W%7>H*F;9(40")$C+\8VG,.;G6E&IM%A+&M24LQY
M*KF,;'>DW18T:G591O)/;*\922ARH1TO,Q,<I'L5CF+VN'1=A X%U#MZEHZU
M=35K.I3%,5(3UU3D)#/KC[C$=_J*JA;HZ9L:4+?(61DI,LE>R?[8\L.83PK$
M7R)R-@&6K4;3:M39O$4]6Z,#=Q"SD_%R\8])*SLJU55),6.MD:*("LH*JISN
M#]ZF^X:@KKS5KHC2UZUN+!FG49E(E(@#,3PB92V2E-<BNHFT-((]6D2F9]8<
M->L@-:.R;>1$R5HG9-PV;Q-0KZC$]EE4U'K-K(O6,<Y<-C*QL W=^I>K%[@0
M1 1$/ !LE'2N*3W'%'21/'(3Z1>:BL0%EM'Q RP]D&N3AT)I!$J_>BY;_GL7
M28]CN.=[E$%T5B]2B4/E,4![5 W >FO5IDK#**MMQ*VAAZX\8B2=%<*P\P":
M<PD05$3ICV-Y1B0P$]:S >A52]WYJ0?\,PAMT'4,109P\/'?Q#?]@[?PTA%=
M(0-(0-(18=0J8%$V^QC 4-@WZCX;_8&_3?2$$6865LDDI6V*RR,<W(D:R/DC
MF3$I5?F1A&RA1 Q7+TG_ !S%'N12,&WS&#9"#04[1D@FT2*""2)2MTD4R=I4
MDDB=A2)AV]HE3(3X;[ &I520ADNJGH2)F6)EY08025$2SB/WF'F"R46ZT.IG
MR7:\05>T5NP.ZS.4BK1EFLV0<K,9".1KV+H]*782+-%R_:.S.DVXD3._ BA
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M8E@$12* =! V_<(CL _)VE PF$ *83 'AMU'6L6ZM3P6MMLX91LY3P;[:'/
M""C/H*1:R%N;)=PM$B-9]J3<5'L+YO?YPD -SO(A3=1$1_\ IBH ^(:4SRJA
MA+RQ)1Z>^4379:S+*#VDY07(FHDH11-4B:B:B8]R:A%B=Z1R&#<!(H7J _'4
M^)<>^D(H;<2B #L.W0?L^_2$$"*#Z]9I";4_-8P)EH&'ZB8BC_<IYQ^0H_*
MD5$&R9NH]I3]>NH%H6L2;5I/D#^,0J7HZ3G!'S*AG-%*%F,'S=.3D(15PXF:
M->(U<8>],%2D_P"10L[ YI*I2;;RC>G<%1<-Q.?99,2AN%RMZ*'X*\J(/\2<
MT^Z8!BU7%^O2F=$)*'B,_N,$#&_)BH7&PEQQD2%F,,9D !5-C6^@V9.Y4>[L
M5>4:SMEC5N_1:QBB<JD:LHL0@@*J*8B(!-K+/4$IK:1>JG1DI.( .05X'V&+
M>W>&GT"DO""7P)2R^R4H-%HB\'<9X++6?'S9ACV'<Q_ZMR7+-G3EI$O5H9N<
M EQA/4!$)V"0 2I'611(N\4$@*"<VVO6Z2^[IJJ>Q4"U+KEK"4R2%**9S4G$
M$RD#CF!E$=QJ+-M^UN7:I06Z=$C\1&)RZ^/2.$3GGS;OO-_-<C>YY=[%T* 7
M=QN+**=4P,ZU6Q6.F1X[0((-UK#-%+YCQ781'<" /9L&OIOQ%L*V\<[30PW2
MI5?*A,W7")J)/\(GD$Y"4IYG&.#>1M]UF_+LXT[52I&5$-IDD  93EG[YPR+
M^G^C6R*9 MR-5P86IA7P@E4\<3,SF?M,:K?#BB$N.A;B?B(  ETP$@,/"*?Q
M^W8?Z>.JYBN?6A7;8E2G^&6)'GG]\1([+JDAAS2V/CQF('3_ $Z*UN? WH\_
M\L3'"PT9I6%P.G]/#4.I2/[L$%;YQU#PZ"64>I72O,3"PV_/(Y^PR,5VVWZ
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M  %V@B =[I$W4P@ D[=MQUN6R(J'?2M)EE'%'U%-[:JK>EA-2TG=@,^R)]S
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M'=M5?);P>*5/4H5)QDD DD]S7,=9H&(,XZ VIOJR;\W/5;?8M:7-J)24LN%
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M_LU?A'=9[52\[ >UMB24A60R]B8TS)4K7HT1'_N$DG8;*[BV8;;CLX<$*38
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MNI7B(3;N))N99$QQ*L4G:8G8J0P:T9?;?RAP'N:E_P"(_,6EY14V@J*D=I)
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M.;1#%5L=Z9P!RF[U 2#H8=]:QXQX6W!LW?M1O2Y%KY7YETI"2K49N*SF ,O
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MKUN792*JFWC'K']!,@38? \>Z.8=_@72$'1%0%"]P;"!@[P$O4#%$Q@(8/M
M2%#2$>VD(+MCKL7:8*<K4XS1?0=BC)&'EV*H;IO(^4:JLGJ"@#ON19LN8H_<
M.HZ:H%OJ$U--,5(4%"7B#.**X4B;E3+I*H TZA(^4<Q6;?9KX535C+2\3YBO
M^!,ER]DLU3JM:OZ*]OJ5BG:O"-[&X2:/'2!'C*-7@W0N4U?5"95,J@E()DQ
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M%95VLO(2ZQ1 0/)/1!1PF!A #"BWV B8? I0V\-(09](0-(1KY-JB^9KLG"
M.&[PAVRZ AN15%8ADU"J?83L$=Q_OVTA!8K3U6,7/49-8QGK!$R\2Z<"/?*P
M9#E(BL8QA^=VR P)+ '4-@,/CI"([.6@O+-(V>2Y6SI,:\-J/,,8V%Q35I=Q
M-Y"Y>VUR1NK%04O'0)TY12GN9%4&S2J,RJ/9ARF*KPY&I>PR$$KCG>LH<>;_
M $JBWK',)C_'G*[)3]'!W'F*N#R=R#QTJ%>H:*I%YNO&:K0K&K2)X$SJ71CG
M?I()_()MTQ/N(:C0)GR$XEN_#(=2!$J%BKL!:823K=DBF$Y SS!W%RD1*M4W
MS"3BWZ1D73%XU<$%%PV<('[1*< _>(:@I*UVAK4U32BBI004K!DI)&1!S$HD
MUMNIZZC52K0DM+'J3(2/C,1R->X][*UOQ8_L.9N)41(77&BBCJ7L.)V0&=VJ
ME$.)W3I:N(  GL582$#B5LGL\:%^"I"@&NX>'OJ(#Z6-L[R<(9TELOK427$J
M5/2M:L2!@)*41@ ,@(XXY/X1J*&I?O\ M5$ZA9!+*!()DD#!*<)&4S)(QCGN
M4240551714;KH+';N&ZJ1T5V[A(?S6RR2A"*I+)"&QB&*!@'Q#78K=;3%/ZA
MM5\KHE^IPH5\6$IJD3,RD,>F$<RNTE2PXIG<E.$7$8)"D#$CS C)CY&1AU?/
MAY*3B5S""GFQ,B]C%3& >AS'8N&QS" _:(]=6FNM%)=0ERX4-+4I2))[K*')
M#P&I)D,>D5=)>:RB'8HW7&$:0F3:B@2!F!))& .,LIXQZ2LQ,3JA59V8EYM0
MHB8IYF4?RQRF,.YC :0<N3 )A'?QU(I;)9:7U4UOHZ=4Q@VRVCX3,'TI&(.(
M,5-5<;G4H4S65#[K:Y$A;BE RQ$P209'$>V-</7QZ^'_ ,.^W]7<.W[=79]*
M:IPNU(#CJ@ 2KU$@9 DS) Z#I% C\O5H].L *EAJEE.6<ND\H']__IM_9HT
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MMO;*YDW9LJ5(PZM^SDC6VHS5I\$J,Y>P91JK>_%%CW?JKM"&KND?ED8(U?\
M.E^Z.9_DA[+?-+ BS^1K55:YTI38HJHS^-#J+S?D$*8YCR-*>G+-HN"$#Y_(
M]23?P$-=@['^I3:UT2BAKU.T]4H ?FI2E )Z:M4ONCE7=?!N[K0\:ME+#S /
M_9J4HX>S2(BIL5<L50D%HFVU^<JLH@H9)6/LD4_@WA%"=#)^1)(-CF.40VV
M!'<-;[IKI0W-D5=+4,.M*R+:@H'WC"<:GN%#=:.H[#]'4A:4B?HP_&-(!R&V
M[3E-O]^P_O VQ@WU4@.+([:%J!.8$Q%!ZT_S$*1_:$HJ(@4 $1 -_O /[1#4
MY=/4($U(5]D.XQ_M6_MB@J)E*)CJ$( !N/>/:.WVE*.PG#_=WU $+*2M8*4C
M,G"/4AQU813(4]XE U >?A.%8QC@G-6:91O#XHQ3?;Z]<K%1(:O5J2=,"&,&
MX&<2QT4XML3;XJ+%UC%PWGM*TF5SN5&PL3P6X$G#/.,EH-HW^X@&GIUX^(/[
M 8G!XO\ ^7[S=?5XV?Y-W"-Q'6A\E=:FU-RVLE^<E'YE&[J0)YE<@2JI]-RB
M[4+OU =<U;[^J*VO4RJ;;#;ZW\1J6E*$B6$Y@J*IYB7VQO+:/T[UR*I+UZ4Q
MVL"0E2E'["!'2O@#B9Q]X:T9_$85QHWAF[&*</IJ::-SSE^MJD<V.Y4%_*JE
M&2E9!WY8@F@0Q$A.(%(0H;!KC'<N\-Q[VK=5]J'%,MJU( 40D$X'TC#+S)CJ
MC;NR=O;4:U6IA J%I"5*(F9#'/&4);R7Y-Y!Q%B>H\J,>T5WD'"#:JR<KE.D
MNH27A,H5^-EF3=:LWE)BY#UC6+ILJ04K+&*-_5)L%5%TQ,9OY9K(TY4E80^$
M=D=1BK[)#I[<XRI[34M]IZ83[/Z""6SRMDANYI&-.8T'AC*& .64.SK=,R?C
M>(F&]):6JVPX2,=BS(<1.2,OZF.N4;W%K]A0633<NTP24216.B(S%:=1T_#/
M#RB!*4H2$(GH D/*%MX_XLREBIW=,!WQ1ME/CU&Q;9;#-TMS]"=M[&O.5S(+
M8=R+&R:+G]4#3VZ9!C)@QC"ZCA31<%%9+O/Y'L.!0BHPS9M2*DPC8*K1 "UD
M4H&/:PT7&1XF,8]=B&S!-!JW<N3C^=Y1" F41Z 8=(0IC9!)JW1;(ID1103*
MDDDF7M(0B8=I2D+\"@ :0CWTA TA TA TA TA!<F8$'RB,BQ5]%-,C&.Q?E*
M!^WN*(*MG2(F*#IDY#H<@CN'0Q1 P .D(0#*V):GGME',K*I.X_RG12S3S']
MWJLLZA[32I:8B5HES.5298&0-+Q+Y!0I7;0X"FLGLDLF [#I"&L7+"V3L%<:
M*9Q2XP*R;S,>:G4G7+AR/F8^0DD:X^D&)G^5N0&2)87AY!]<YIMWHQ3<7/F*
M2"Z*:0IHH; A"5<'63G&O&XG(G-^>+%'XZP AF&LQ]#I[.-HN%8.C8GLUCIX
MS;FMH(/IJT6"92@CNE59"1765D' B!>\>J$.PPGS(E\GW#'-:M^*R4&)SK2K
M/D#"<]'WR%O!YJ"J2,._E(VZL85FD2GV0(6<;NP0(L]0 #'1%7SB"4?09&9C
MP@$2.4.R3MU6=S;FO-K- NK/&$!60K3298+S\<W4[/+5>0Y'"D@U3W.78ZB)
M0V-ON ==2W&W75 MKT1&HLM-ZBD+E[X*61Z'ARXPD@YRY2\>V& :-SK/W-\A
MJ\]8LVI";+*NW\LB9!J@0W3O.H4NX^/AJMI+ENNUN@6BX.-LX>D.+2)S\$_L
MBT+MMGNZ%*K*5LJF1,I$_NAH]C]K3V^[BMZU]QBQTD+L0,#J 2DX HE5 %$U
M4"P<FT0\I0#;E$  H!U#<-M; H>9.6+<V&6;E-L"4O2?M)1,_;&'7#B#9->X
M7WF0.I ) EF1GU@JH>S5[<R"WG_^/46N/7=)S:KFHB.^WXD_K@ (=-5*^;^6
M%#"X?ZJ?^K%#_P"D7&W_ (),O-7[X6VC^W1P?QVN@YJ?&3$C)RW[?+<OJTA.
M. ,3\)P5FQ?B)P^T>N^L>N?*7*=V2&JFY+#'4)44'[4)!^TQ>[3QWLFTZ_TZ
MC0-1!.9Q&69,.UCJU!P#,D= 0D1"1Z8 ";6)CVT8U( %V*!$622*1 *7H&P:
MPZM6JYC7>'777)SFI:CCYSG&94ENM5()--(3+P A/G&>\-Q^1V>'G&2Z,AE%
M\F=5I05;&Q&SK@1OZP4BQHK>>60%F K%:CLX,B'>4A@ZZDI<5DK*)_:;3BB&
M>/\ FM8BYYN50<2W&^B8TQ=E)EC*^0V6,IA1LQOF+R!8RX9*K$3+JLJ^I5E'
M$FB1D@H"JD@B"ARJIF)V:F MGX/BZPTN#%7P](V#]RKQPY)++3+Q6?XU<R9D
MB!%)1RXF8;''(21B_0ILA,Z7=H-Z'G.#;=I$]R,TIE "AT=@.O806(7@S>8N
M8D\1J9A\OAK"Y&H^5L;XL^@)OKU3']<G36U?&D9>7ARJQ&,XVV,6KR+!,IW3
M5J=1F10B0!I")!5)1Q:#JLH14[>,(8R,A8"F'=42[E6;09?F!57?Y3. _**&
MX%$QO!"#A'QS.,:(L62)4&R!0*FD&YMA\1.8QMS'5,;YC"(B(B.XCI",_P#C
MI"!I"!I"!I"!I"!I"!I"-%.04?,LP;ND5 ,DJ55JY:&.@]9+@8!!=FY1$JC=
M0-NH@( (=!W 1#2$%;ZK-UC=.P-U92+W**4_'MP.N@F0=P&=8H )P[/$SA /
M)^)BETA#5<Z<;(NU\7)/#6"(FN(Q?ZSK^08NIOY)R%3MJS#)37)=EJ<S(@5\
MHUC+M(HN$5CF(JBF=QN<@I@8-(01<58QK.%'V9>7F4^.-#P5-5RGV1>(KN-)
MU_<IICCZ.8(V2[O)2+B3M* VM-BDX<HIIPK5(ZC9!(BZQU#"!0,L1'BDA0TJ
MQ!AN''O%]%_\GJ9!/BL9*QSDA;N;V'\Z5 (PMVO6.L@'<0\[A[.RH"\DR)U9
M6ZM21ZA5S1[]LS1*0J;ANJ!B_P P27B(B02VG2C!,/RYK6E>MX30AHN(KD[+
MY1R5BO$D?"VR*+-04J2_WF(C)AK(0QSD]4BE "[6 @CL!DP-\-2/E:><] G[
MX$DB1RA'\PK9I#GQQ.J- M--BL=,,<9BLE@J<K%V3UCJ*BAIE;=KJ*QDVUBW
MRZ:<L0L0"S42-%05.85 $H!4 E(D,HDEAE2@LI&H90X3F/FRY\><"6/*>/ZM
M#7*SQ-@H4(P@)Y\XC8IS^L[Q7Z<99T]:[*H$9FG06$0_$!-OCOJ$@'.)L)IC
M+-.=(;+.5\!9J)0K5>JSB..S;CBS8\AYBMQ5J@I)[,04G5)*OS$M/.T92MV6
M/01(Z16$KMJY(<R::@'+J'MHG.4(:CAS*N:JS6.&')BQ9LMN2*QRDMT/CW-5
M!LJ<4%5I,_D9&;+4Y/'4>QC6;FK!2+C%$A'C<YUBNTE1.ILJ3K&,,H\(!S@I
M9Z,CQJR1G&6J&5N.L[)PUB3Y?-<,<B<;2S:]+VB60<1GD8MRU'S\>\DY!^]B
M%FT61-B_6C%W)&YBB@< UX4@YQ$"1E#Q,X8GR'F=KCN_T+$_&NQ*7''SB-R+
M6>1-!))6&'1MT2Q=1KN.M;"'DII8]1%RN@ZAE$TDGI3;$60.7?7@0E)FD2,>
ME2B)$X"%VQ!08'!.#L58:GY4;NYH-9@J^U7>,0D)"9>0@ 9J[8QBAGBR"+-<
M-FICF$6Z290$XF+OJ*(84HL3*V1<JMA2&+B._N+ (+=SMX0X '_?7B(^6)5#
M  BW1'M$/Q&VZ:0@_HMT&R2:#=)-%%(I2)II% A"$*  4I2E     -(1[>&D
M(&D(&D(&D(&D(&D(&D(&D(&D(M-W#T /V]0#XAX#]H!]VVD();RDM/4J2,&^
M>UJ26-W+JQ9D@8NS" [C(Q*A18.^X>HF I%1_P 8:0C!=N;4R24:SM?:V:+5
M240<.H$B)EU6ZY1263>0$FIVKI*I&$IR)** )1$.T=(0F&)\<\;,0S%A>8PH
MU'QA-6<4B3OHX,M7DY$K5119)J(/B(&1C6ZRICIMD.UN4YA,!=QWTA&_RUA]
MKF&;PI,K6%1A&8DRI'97"-;-V[MM9Y.%K\]$P;)RZ,83-6[%[.>K[DP$3'1*
M&D((=NP]D-SRPQ9GFM.:D\J4-BVXXJNT)/+2[6PL6EDLL%:$+'5%F22T:\<D
M7@2-E6[H$_RC]Q5-^FD(*?N/0DO/\).03*OJ+(3S:I,)N%<MV:\@NTE*Y9X*
MP,G:+%KLY=*-5XTJ@$3$#&[=@$/'2$5PEB/,3S-,KR0SE*T$UC6Q' XEIM>Q
MJG-FB25L)T]OFK5,N9\$'(S%AE%$B)LTRBBR11$ 44,;N!""Q'<):'3KC"R+
MO*UP;8>J^5'N<:E@>2>UMKCZL9.?/'<LK)L)%5BG9W%<9SD@YD&L0=V9FT?+
M"=,-@ H(0YB?+C*WS$)+NJ)$9&L%<,*U>EE*G%3CN$75'O,O$V.99D;18J'+
MN8Z;@@]P (!OI"#05I=IO_JEVM2CCB)C-XPY)&=6*8=_S)%8A64><Q!V/Y2:
MQ@'\)_CI"#!#5F)A/.49-3 \=@'K)%PNJ]DG0EV_ZF0='4<K;_ !'8/@ :0@
MQ!I"!I"!I"!I"!I"!I"!I"!I"!I"!I"!I"!I"!I"*&VV'??;[OVZ0C13/T#T
MQ_U!]*]+Y9N_ZIZ3RNW;YM_6?)MVZ0A+%OY0^;_V[S/-[Q[/T=^H=]]NO9^G
MOR]_]W2$7&]+VA]*_G%Y>R?;Z;N_#O\ )V_JG\__ .?[>ND(\W/JO)-ZC^=/
ME=H]_F?I3L[=OF[_ #/R]NW???IMOI" /Z?[G'U?^:NVZ/G>K^O^G[?++MM]
M#_*\C_'V?+OOI"-G7_Y3]Z?H/H'K.Y3M^K[_ %/;N-W;?7O^;[M_W[:0A4D/
M+\M+R?+]/N3RO3>5Y/9VCOMV=.S?QV^/W:0C.TA TA TA TA TA TA TA TA
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>t1700488_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 t1700488_logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *0$+ P$1  (1 0,1 ?_$ ,(  0 !! ,! 0
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MHNTUYX$G687*&N=VI-RA72(C[)J]EBA._:(Y( @4IUXUKZ>AE!ZB(]:>@^5
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M'/DS\8=;Q!B2]NTZY:\:8KOVOF0;(9PY56D:K!,7M%?78IDB/EDYV+,=E+&
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M]FW?W+$/AXUPD?OMI@*LWKMJRW/K+D(91-PE -F>-J0=1'HF/MB_.@'3\@!
M0YY@.P+#%;9&G'C\U5T0IZE4UUQC&5M[(MD4+1?)4?ON1[F=+H/N6:WO""_<
M(=Y0,5HA[#%(0ZIH$XY6[P$5/,Z$(F"O0  #Z  ?S '(#&- #0 !W)$G=?>3
M =BA.(#L1.G)40"<*4X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X18\_+#_\ G)M[_P"C\S_6V'"*"/"!_P#!FA?[)K_5>2=@
8O3EF!_5_E&_SN0O*_7")PB<(G")PB__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
